BD To Acquire Bard for $24 Billion
BD (Becton, Dickinson and Company), a leading global medical technology company, and C. R. Bard, Inc., a medical technology leader in the fields of vascular, urology, oncology and surgical specialty products, announced today a definitive agreement under which BD will acquire Bard for $317.00 per Bard common share in cash and stock, for a total consideration of $24 billion. The agreement has been unanimously approved by the Boards of Directors of both companies.
Aligning Technology, Leadership and Organizational CultureBy Dennis Morrison, Chief Clinical Officer, Netsmart.
When an organization recognizes the need to upgrade or change technology, a great deal of effort goes into the selection process. But once that decision is made, executives all too often leave the implementation to the IT department and the vendor’s support team. And that’s when problems start to begin. Because implementing, upgrading or optimizing technology can be problematic – and the issue is usually not the technology itself.
A major change in technology means a major cultural shift. Leading an organization through such a shift calls for strong support and critical intervention from the highest levels of management. To illustrate, let’s take a look at a stalled implementation at a large nonprofit organization that provides child and family services and the steps the CEO took to rectify it.